• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Erratum to 'Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario': [ESMO Open Volume 7, Issue 2, April 2022, 100406].《“评估2019冠状病毒病对意大利肺癌患者诊断治疗途径延误的影响(COVID-DELAY研究):来自真实世界的更少病例和更高分期”的勘误》:[《欧洲肿瘤内科学会开放》第7卷,第2期,2022年4月,100406]
ESMO Open. 2022 Apr;7(2):100471. doi: 10.1016/j.esmoop.2022.100471. Epub 2022 Apr 1.
2
Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario.评估 COVID-19 对意大利肺癌患者诊断-治疗途径延迟的影响(COVID-DELAY 研究):来自真实世界的病例减少且分期更高。
ESMO Open. 2022 Apr;7(2):100406. doi: 10.1016/j.esmoop.2022.100406. Epub 2022 Feb 3.
3
Erratum to 'Adjuvant endocrine therapy in HER2-positive breast cancer patients: systematic review and meta-analysis': [ESMO Open Volume 6, Issue 2, April 2021, 100088].《HER2 阳性乳腺癌患者的辅助内分泌治疗:系统评价与荟萃分析》勘误:[《ESMO 开放》第 6 卷,第 2 期,2021 年 4 月,100088]
ESMO Open. 2021 Jun;6(3):100158. doi: 10.1016/j.esmoop.2021.100158.
4
Erratum to 'Major advancements in metastatic breast cancer treatment: when expanding options means prolonging survival': [ESMO Open Volume 7, Issue 2, April 2022, 100409].《转移性乳腺癌治疗的重大进展:拓展治疗选择即延长生存期》勘误:[《ESMO 开放》第 7 卷,第 2 期,2022 年 4 月,100409]
ESMO Open. 2022 Jun;7(3):100472. doi: 10.1016/j.esmoop.2022.100472. Epub 2022 Apr 7.
5
Erratum to 'Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome': [ESMO Open Volume 6, Issue 1, February 2021, 100005].《“COVID-19 之前及期间癌症患者血液学和生化参数的纵向特征揭示与预后相关的特征”勘误》:[《ESMO 开放》第 6 卷,第 1 期,2021 年 2 月,100005]
ESMO Open. 2021 Apr;6(2):100056. doi: 10.1016/j.esmoop.2021.100056. Epub 2021 Jan 28.
6
Corrigendum to 'COVID-19 epidemic strongly affected cancer research in Italy: a survey of the Italian Cancer Society (SIC)': [ESMO Open Volume 6, Issue 3, June 2021, 100165].《“COVID-19疫情对意大利癌症研究产生重大影响:意大利癌症协会(SIC)的一项调查”》勘误:[《ESMO Open》第6卷,第3期,2021年6月,100165]
ESMO Open. 2021 Aug;6(4):100243. doi: 10.1016/j.esmoop.2021.100243. Epub 2021 Aug 2.
7
Patterns of Delaying Surgery for Breast Cancer During the COVID-19 Outbreak in Daegu, South Korea.韩国大邱新冠疫情期间乳腺癌手术延迟模式
Front Surg. 2020 Oct 8;7:576196. doi: 10.3389/fsurg.2020.576196. eCollection 2020.
8
Erratum to 'Safety and preliminary activity results of the GATTO study, a phase Ib study combining the anti-TA-MUC1 antibody Gatipotuzumab with the anti-EGFR Tomuzotuximab in patients with refractory solid tumors': [ESMO Open Volume 7, Issue 2, April 2022, 100447].《GATTO研究的勘误:一项Ib期研究,将抗TA-MUC1抗体Gatipotuzumab与抗EGFR抗体Tomuzotuximab联合用于难治性实体瘤患者》:[《ESMO Open》第7卷,第2期,2022年4月,100447]
ESMO Open. 2022 Aug;7(4):100549. doi: 10.1016/j.esmoop.2022.100549. Epub 2022 Jul 13.
9
Results of Multilevel Containment Measures to Better Protect Lung Cancer Patients From COVID-19: The IEO Model.更好地保护肺癌患者免受COVID-19感染的多级防控措施结果:IEO模型
Front Oncol. 2020 Apr 22;10:665. doi: 10.3389/fonc.2020.00665. eCollection 2020.
10
Corrigendum to 'The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer': [ESMO Open Volume 6, Issue 2, April 2021, 100078].《肺免疫肿瘤学预后评分(LIPS-3):对PD-L1≥50%的晚期非小细胞肺癌接受一线帕博利珠单抗治疗患者的预后分类》勘误:[《ESMO Open》第6卷,第2期,2021年4月,100078]
ESMO Open. 2021 Jun;6(3):100137. doi: 10.1016/j.esmoop.2021.100137. Epub 2021 Jun 3.

引用本文的文献

1
Pleural mesothelioma incidence and use of systemic treatment decreased during the COVID-19 pandemic in The Netherlands.在荷兰,COVID-19大流行期间胸膜间皮瘤的发病率和全身治疗的使用有所下降。
Sci Rep. 2025 Jul 16;15(1):25677. doi: 10.1038/s41598-025-10054-6.

Erratum to 'Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario': [ESMO Open Volume 7, Issue 2, April 2022, 100406].

作者信息

Cantini L, Mentrasti G, Lo Russo G, Signorelli D, Pasello G, Rijavec E, Russano M, Antonuzzo L, Rocco D, Giusti R, Adamo V, Genova C, Tuzi A, Morabito A, Gori S, La Verde N, Chiari R, Cortellini A, Cognigni V, Pecci F, Indini A, De Toma A, Zattarin E, Oresti S, Pizzutilo E G, Frega S, Erbetta E, Galletti A, Citarella F, Fancelli S, Caliman E, Della Gravara L, Malapelle U, Filetti M, Piras M, Toscano G, Zullo L, De Tursi M, Di Marino P, D'Emilio V, Cona M S, Guida A, Caglio A, Salerno F, Spinelli G P, Bennati C, Morgillo F, Russo A, Dellepiane C, Vallini I, Sforza V, Inno A, Rastelli F, Tassi V, Nicolardi L, Pensieri M V, Emili R, Roca E, Migliore A, Galassi T, Rocchi M B L, Berardi R

机构信息

Department of Medical Oncology, Università Politecnica delle Marche, AOU Ospedali Riuniti di Ancona, Ancona, Italy.

Oncologia Medica 1, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.

出版信息

ESMO Open. 2022 Apr;7(2):100471. doi: 10.1016/j.esmoop.2022.100471. Epub 2022 Apr 1.

DOI:10.1016/j.esmoop.2022.100471
PMID:35378403
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8973259/
Abstract
摘要